All Releases
  Theravance Reports Second Quarter 2010 Financial Results
Jul 22, 2010
PDF 98.6 KB Add to Briefcase
  Theravance to Report Second Quarter 2010 Financial Results on July 22, 2010
Jul 8, 2010
PDF 22.1 KB Add to Briefcase
  Theravance to Present at Investor Conferences in June 2010
Jun 2, 2010
PDF 25.4 KB Add to Briefcase
  Theravance to Present at Investor Conferences in May 2010
Apr 22, 2010
PDF 25.3 KB Add to Briefcase
  Theravance Reports First Quarter 2010 Financial Results
Apr 21, 2010
PDF 89.2 KB Add to Briefcase
  Theravance to Webcast 2010 Annual Meeting of Stockholders on April 27, 2010
Apr 20, 2010
PDF 17.7 KB Add to Briefcase
  Theravance Announces Initiation of Proof of Concept Phase 2 Clinical Study with its PUMA Compound, TD-1211, for the Treatment of Opioid-Induced Constipation
Apr 14, 2010
PDF 87.1 KB Add to Briefcase
  Theravance to Report First Quarter 2010 Financial Results on April 21, 2010
Apr 7, 2010
PDF 22.0 KB Add to Briefcase
  Theravance Announces Closing of Public Offering of Common Stock
Mar 24, 2010
PDF 21.4 KB Add to Briefcase
  Theravance Announces Pricing of Public Offering of Common Stock
Mar 19, 2010
PDF 18.2 KB Add to Briefcase
  Theravance Announces Proposed Public Offering of Common Stock
Mar 17, 2010
PDF 27.1 KB Add to Briefcase
  Theravance Announces New Employment Inducement Awards
Mar 1, 2010
PDF 20.8 KB Add to Briefcase
  Theravance to Present at Investor Conferences in March 2010
Feb 25, 2010
PDF 21.0 KB Add to Briefcase
  Theravance Reports Fourth Quarter and Full Year 2009 Financial Results
Feb 11, 2010
PDF 157.5 KB Add to Briefcase
  Theravance to Report Fourth Quarter and Full Year 2009 Financial Results on February 11, 2010
Feb 3, 2010
PDF 11.6 KB Add to Briefcase
  Theravance Announces New Employment Inducement Awards
Feb 1, 2010
PDF 11.1 KB Add to Briefcase
  Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nosocomial Pneumonia
Jan 28, 2010
PDF 33.1 KB Add to Briefcase
  Theravance to Present at the 28th Annual J.P. Morgan Healthcare Conference
Jan 7, 2010
PDF 22.1 KB Add to Briefcase
  Theravance to Present at the Deutsche Bank 2009 Biotech Boston Confab
Dec 2, 2009
PDF 22.1 KB Add to Briefcase
  Theravance Announces New Employment Inducement Awards
Dec 1, 2009
PDF 20.1 KB Add to Briefcase
Showing 1-20 of 213 Page: 1 2 3 ... 11  Next 20
= add release to Briefcase


©2010 Theravance, Inc. Theravance, the Theravance logo and Medicines That Make a Difference are registered trademarks of Theravance, Inc. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners. All rights reserved.

VIBATIV is a trademark of Astellas Pharma Inc.

RELOVAIR is a trademark of Glaxo Group Limited. Mark is intended for U.S. and subject to FDA approval.

Terms of Use     Website Admin Contact     Theravance Contact     Site Map